Novavax, Inc. (Alumni)
1 known investors
Find your way into Novavax, Inc. (Alumni)
Sign up to see every warm intro you have to Novavax, Inc. (Alumni)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novavax, Inc. (Alumni) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novavax develops protein-based nanoparticle vaccines paired with its Matrix-M adjuvant to produce broad, long-lasting immune responses. It advances a pipeline of vaccine assets targeting areas of unmet medical need and pursues partnerships to commercialize its technology.
Investors · 1
Frequently asked questions
- What does Novavax, Inc. (Alumni) do?
- Novavax develops protein-based nanoparticle vaccines paired with its Matrix-M adjuvant to produce broad, long-lasting immune responses. It advances a pipeline of vaccine assets targeting areas of unmet medical need and pursues partnerships to commercialize its technology.
- Who are Novavax, Inc. (Alumni)'s investors?
- Novavax, Inc. (Alumni)'s investors include Foresite Capital.
